Related Experiment Videos
Adverse reactions associated with ticrynafen use
JAMA
|February 22, 1980
Summary
Ticrynafen, a uricosuric diuretic, caused serious adverse reactions in three hypertensive patients, including kidney failure, stones, and fatal bleeding. These preventable events highlight risks when replacing thiazide diuretics with ticrynafen.
Area of Science:
- Pharmacology
- Nephrology
- Cardiology
Background:
- Hypertension management often involves diuretics.
- Ticrynafen is a novel uricosuric diuretic.
- Thiazide diuretics are commonly prescribed for hypertension.
Observation:
- Three hypertensive patients experienced adverse events while on ticrynafen.
- One patient developed acute renal failure.
- Another patient formed a renal stone.
- A third patient suffered fatal hemorrhage during warfarin therapy.
Findings:
- Complications were linked to ticrynafen's known pharmacological actions.
- Acute renal failure, renal stone formation, and drug interactions with anticoagulants were observed.
- These adverse reactions are considered preventable.
Implications:
- Widespread substitution of ticrynafen for thiazide diuretics may pose significant risks.
- Physicians should be aware of ticrynafen's potential hazards.
- Careful patient selection and monitoring are crucial when prescribing ticrynafen, especially with anticoagulation.